Immune Design CS (IMDZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IMDZ | TARA | PRLD | ||
| Company | Immune Design CS | Artara Therapeutics Inc | Prelude Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 5.84 | 5.13 | 4.33 | ||
| High | 5.85 | 5.21 | 4.35 | ||
| Low | 5.84 | 5.04 | 4.13 | ||
| Latest | 5.85 | 5.12 | 4.20 | ||
| Change | unch | -0.18 | -0.27 | ||
| % Change | unch | -3.40% | -6.04% | ||
| Volume | 103,800 | 293,108 | 111,263 | ||
| 20-Day Average Volume | 409,005 | 612,932 | 537,892 | ||
| Previous Close | 5.85 | 5.30 | 4.47 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 5.84 | 5.27 | 4.64 | ||
| 20-Day Raw Stochastic | 100.00% | 21.77% | 21.74% | ||
| 20-Day Relative Strength | 88.63 | 45.84 | 49.84 | ||
| Weighted Alpha | -20.50 | +15.97 | +250.56 | ||
| Today's Opinion | 88% Buy | 32% Sell | 80% Buy | ||
| Previous Opinion | 88% Buy | 16% Buy | 88% Buy | ||
| Last Month's Opinion | 56% Buy | 16% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 03/25/19 | -3.04% since 05/08/26 | -12.76% since 05/08/26 | ||
| Low | 5.84 on 04/01/19 | 4.97 on 05/14/26 | 4.17 on 05/15/26 | ||
| High | 5.85 on 04/01/19 | 5.52 on 05/11/26 | 5.14 on 05/11/26 | ||
| 1-Month | |||||
| %Chg | +0.34% since 03/01/19 | -1.92% since 04/15/26 | -23.19% since 04/15/26 | ||
| Low | 5.82 on 03/14/19 | 4.95 on 04/29/26 | 3.89 on 04/23/26 | ||
| High | 5.85 on 04/01/19 | 5.68 on 05/06/26 | 5.51 on 04/16/26 | ||
| 3-Month | |||||
| %Chg | +350.00% since 12/31/18 | -21.51% since 02/13/26 | +90.13% since 02/13/26 | ||
| Low | 1.22 on 01/03/19 | 4.80 on 03/30/26 | 2.06 on 02/19/26 | ||
| High | 5.85 on 04/01/19 | 7.50 on 02/23/26 | 5.54 on 04/15/26 | ||
| 6-Month | |||||
| %Chg | +73.08% since 10/01/18 | -7.26% since 11/14/25 | +178.95% since 11/14/25 | ||
| Low | 1.10 on 12/24/18 | 4.72 on 01/16/26 | 1.29 on 12/03/25 | ||
| High | 5.85 on 04/01/19 | 7.82 on 11/24/25 | 5.54 on 04/15/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 282,935 | 291,823 | 281,619 | ||
| Shares Outstanding, K | 48,365 | 55,061 | 63,002 | ||
| Annual Sales | 2,200,000 | 0 | 12,140,000 | ||
| Annual Net Income | -54,760,000 | -57,440,000 | -99,500,000 | ||
| Last Quarter Sales | 480,000 | 0 | 5,640,000 | ||
| Last Quarter Net Income | -13,600,000 | -17,310,000 | -16,460,000 | ||
| 60-Month Beta | 3.48 | 1.53 | 1.11 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.37 on 03/10/26 | -0.13 on 05/12/26 | ||
| Earnings Date | 05/01/19 | 08/10/26 | 08/13/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||